• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白自身免疫在多发性系统萎缩和帕金森病前驱期的衰退。

Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease.

机构信息

Centre for Neuroscience & Stereology, Department of Neurology, Copenhagen University Hospital, Bispebjerg-Frederiksberg Hospital, DK-2400 Copenhagen NV, Denmark.

Copenhagen Center for Translational Research, Copenhagen University Hospital, Bispebjerg-Frederiksberg Hospital, DK-2400 Copenhagen NV, Denmark.

出版信息

Int J Mol Sci. 2022 Jun 12;23(12):6554. doi: 10.3390/ijms23126554.

DOI:10.3390/ijms23126554
PMID:35742998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224313/
Abstract

Multiple-system trophy (MSA) and Parkinson's Disease (PD) are both progressive, neurodegenerative diseases characterized by neuropathological deposition of aggregated alpha-synuclein (αSyn). The causes behind this aggregation are still unknown. We have reported aberrancies in MSA and PD patients in naturally occurring autoantibodies (nAbs) against αSyn (anti-αSyn-nAbs), which are important partakers in anti-aggregatory processes, immune-mediated clearance, and anti-inflammatory functions. To elaborate further on the timeline of autoimmune aberrancies towards αSyn, we investigated here the Immunoglobulin (Ig) affinity profile and subclass composition (IgG-total, IgG1-4 and IgM) of anti-αSyn-nAbs in serum samples from prodromal (p) phases of MSA and PD. Using an electrochemiluminescence competition immunoassay, we confirmed that the repertoire of high-affinity anti-αSyn-nAbs is significantly reduced in pMSA and pPD. Further, we demonstrated that pPD had increased anti-αSyn IgG-total levels compared to pMSA and controls, concordant with increased anti-αSyn IgG1 levels in pPD. Anti-αSyn IgG2 and IgG4 levels were reduced in pMSA and pPD compared with controls, whereas anti-αSyn IgG3 levels were reduced in pMSA compared to pPD and controls. The results indicate that the impaired reactivity towards αSyn occurs prior to disease onset. The apparent lack of high-affinity anti-αSyn nAbs may result in reduced clearance of αSyn, leading to aggregation of the protein. Thus, this study provides novel insights into possible causes behind the pathogenesis in synucleinopathies such as MSA and PD.

摘要

多系统萎缩症(MSA)和帕金森病(PD)都是进行性神经退行性疾病,其特征为聚集的α-突触核蛋白(αSyn)的神经病理学沉积。导致这种聚集的原因尚不清楚。我们已经报道了 MSA 和 PD 患者中天然存在的针对 αSyn 的自身抗体(nAbs)(抗-αSyn-nAbs)的异常,这些抗体是抗聚集过程、免疫介导清除和抗炎功能的重要参与者。为了更详细地阐述针对 αSyn 的自身免疫异常的时间进程,我们在此研究了 MSA 和 PD 的前驱期(p)阶段血清样本中抗-αSyn-nAbs 的免疫球蛋白(Ig)亲和力谱和亚类组成(总 IgG、IgG1-4 和 IgM)。我们使用电化学发光竞争免疫分析法证实,高亲和力抗-αSyn-nAbs 的 repertoire 在 pMSA 和 pPD 中显著减少。此外,我们证明与 pMSA 和对照组相比,pPD 具有更高的抗-αSyn IgG 总水平,并且 pPD 中的抗-αSyn IgG1 水平也增加。与对照组相比,pMSA 和 pPD 中的抗-αSyn IgG2 和 IgG4 水平降低,而 pMSA 中的抗-αSyn IgG3 水平与 pPD 和对照组相比降低。这些结果表明,针对 αSyn 的反应受损发生在疾病发作之前。缺乏高亲和力的抗-αSyn nAbs 可能导致 αSyn 的清除减少,从而导致蛋白聚集。因此,这项研究为 MSA 和 PD 等突触核蛋白病的发病机制背后的可能原因提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/6587e0e2a7df/ijms-23-06554-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/1b09facb65fb/ijms-23-06554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/7e9bb61db73f/ijms-23-06554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/402ea2d76ee7/ijms-23-06554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/6587e0e2a7df/ijms-23-06554-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/1b09facb65fb/ijms-23-06554-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/7e9bb61db73f/ijms-23-06554-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/402ea2d76ee7/ijms-23-06554-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc8/9224313/6587e0e2a7df/ijms-23-06554-g004.jpg

相似文献

1
Alpha-Synuclein Autoimmune Decline in Prodromal Multiple System Atrophy and Parkinson's Disease.α-突触核蛋白自身免疫在多发性系统萎缩和帕金森病前驱期的衰退。
Int J Mol Sci. 2022 Jun 12;23(12):6554. doi: 10.3390/ijms23126554.
2
Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease.多系统萎缩和帕金森病中抗α-突触核蛋白IgM和IgG的脑脊液及血浆分布
Parkinsonism Relat Disord. 2021 Jun;87:98-104. doi: 10.1016/j.parkreldis.2021.05.001. Epub 2021 May 12.
3
Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.多发性系统萎缩和帕金森病中独特的抗α-突触核蛋白自身抗体模式。
Front Immunol. 2019 Sep 24;10:2253. doi: 10.3389/fimmu.2019.02253. eCollection 2019.
4
Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.帕金森病和多系统萎缩中自身免疫抗体的下降;迈向免疫治疗策略的一步。
Mol Neurodegener. 2017 Jun 7;12(1):44. doi: 10.1186/s13024-017-0187-7.
5
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo.α-突触核蛋白特异性天然抗体抑制体内外聚集。
Biomolecules. 2022 Mar 18;12(3):469. doi: 10.3390/biom12030469.
6
α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.α-突触核蛋白菌株及其与帕金森病、多系统萎缩和路易体痴呆的关系。
Int J Mol Sci. 2023 Jul 28;24(15):12134. doi: 10.3390/ijms241512134.
7
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.患者源性 α-突触核蛋白菌株之间的结构差异决定了帕金森病、多系统萎缩和路易体痴呆的特征。
Acta Neuropathol. 2020 Jun;139(6):977-1000. doi: 10.1007/s00401-020-02157-3. Epub 2020 Apr 30.
8
The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson's Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells.帕金森病和多系统萎缩患者嗅黏膜产生的α-突触核蛋白 RT-QuIC 产物可诱导 SH-SY5Y 细胞炎症反应。
Cells. 2021 Dec 28;11(1):87. doi: 10.3390/cells11010087.
9
Is Multiple System Atrophy a Prion-like Disorder?多系统萎缩是类朊病毒病吗?
Int J Mol Sci. 2021 Sep 18;22(18):10093. doi: 10.3390/ijms221810093.
10
α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.α-突触核蛋白种子扩增检测作为帕金森病相关疾病的诊断工具
Parkinsonism Relat Disord. 2023 Dec;117:105807. doi: 10.1016/j.parkreldis.2023.105807. Epub 2023 Aug 14.

引用本文的文献

1
Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns.阿尔茨海默病、帕金森病和路易体痴呆中的自身抗体谱:在疾病特异性病理模式下,针对α-突触核蛋白、淀粉样β蛋白和tau蛋白的IgG亲和力改变以及IgG/IgM/IgA反应
J Neuroinflammation. 2024 Dec 3;21(1):317. doi: 10.1186/s12974-024-03293-3.
2
The immune system in Parkinson's disease: what we know so far.帕金森病中的免疫系统:目前我们所知的。
Brain. 2024 Oct 3;147(10):3306-3324. doi: 10.1093/brain/awae177.
3
Molecular Mechanisms Underlying Chronic and Degenerative Diseases.

本文引用的文献

1
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo.α-突触核蛋白特异性天然抗体抑制体内外聚集。
Biomolecules. 2022 Mar 18;12(3):469. doi: 10.3390/biom12030469.
2
Predictors of RBD progression and conversion to synucleinopathies.RBD 进展和向神经核蛋白病转化的预测因素。
Curr Neurol Neurosci Rep. 2022 Feb;22(2):93-104. doi: 10.1007/s11910-022-01171-0. Epub 2022 Mar 11.
3
T Lymphocytes in Parkinson's Disease.帕金森病中的 T 淋巴细胞。
慢性和退行性疾病的分子机制
Int J Mol Sci. 2023 Aug 7;24(15):12507. doi: 10.3390/ijms241512507.
4
Identification and validation of key molecules associated with humoral immune modulation in Parkinson's disease based on bioinformatics.基于生物信息学的帕金森病体液免疫调节相关关键分子的鉴定和验证。
Front Immunol. 2022 Sep 15;13:948615. doi: 10.3389/fimmu.2022.948615. eCollection 2022.
5
B Lymphocytes in Parkinson's Disease.帕金森病中的 B 淋巴细胞。
J Parkinsons Dis. 2022;12(s1):S75-S81. doi: 10.3233/JPD-223418.
J Parkinsons Dis. 2022;12(s1):S65-S74. doi: 10.3233/JPD-223152.
4
Global Characterization of Peripheral B Cells in Parkinson's Disease by Single-Cell RNA and BCR Sequencing.通过单细胞 RNA 和 BCR 测序对帕金森病外周 B 细胞进行的全球特征分析。
Front Immunol. 2022 Feb 16;13:814239. doi: 10.3389/fimmu.2022.814239. eCollection 2022.
5
Passive Immunization in Alpha-Synuclein Preclinical Animal Models.α-突触核蛋白的临床前动物模型中的被动免疫。
Biomolecules. 2022 Jan 20;12(2):168. doi: 10.3390/biom12020168.
6
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function.在帕金森病中起作用的阿尔法突触核蛋白,对于正常的免疫功能也是必需的。
Cell Rep. 2022 Jan 11;38(2):110090. doi: 10.1016/j.celrep.2021.110090.
7
Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study.帕金森病患者异常的 B 细胞和滤泡辅助性 T 细胞谱:一项横断面研究。
Neurol Neuroimmunol Neuroinflamm. 2021 Dec 26;9(2). doi: 10.1212/NXI.0000000000001125. Print 2022 Mar.
8
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease.ABBV-0805,一种新型针对可溶性聚集α-突触核蛋白的抗体,可延长帕金森病小鼠模型的寿命并防止α-突触核蛋白病理堆积。
Neurobiol Dis. 2021 Dec;161:105543. doi: 10.1016/j.nbd.2021.105543. Epub 2021 Nov 1.
9
Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease.多系统萎缩和帕金森病中抗α-突触核蛋白IgM和IgG的脑脊液及血浆分布
Parkinsonism Relat Disord. 2021 Jun;87:98-104. doi: 10.1016/j.parkreldis.2021.05.001. Epub 2021 May 12.
10
Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.皮肤α-突触核蛋白聚集种子活性作为帕金森病的一种新型生物标志物
JAMA Neurol. 2020 Sep 28;78(1):1-11. doi: 10.1001/jamaneurol.2020.3311.